Since the onset of the COVID-19 pandemic, the medical field has been forced to apply the
basic knowledge of immunology with the most up-to-date SARS-CoV-2 findings and …

The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

The third edition of Flow Cytometry Guidelines provides the key aspects to consider when
performing flow cytometry experiments and includes comprehensive sections describing …

BBV152 is a whole-virion inactivated vaccine based on the Asp614Gly variant. BBV152 is
the first alum-imidazoquinolin-adjuvanted vaccine authorized for use in large populations …

One and half year following the occurrence of COVID-19 pandemic, significant efforts from
laboratories all over the world generated a huge amount of data describing the prototypical …

The development of vaccines to prevent SARS-CoV-2 infection has mainly relied on the
induction of neutralizing antibodies (nAbs) to the Spike protein of SARS-CoV-2, but there is …

CD8+ T cells have key protective roles in many viral infections. While an overall Th1-biased
cellular immune response against SARS-CoV-2 has been demonstrated, most reports of anti …

The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2
infection are not fully understood. We present a detailed longitudinal cohort study of UK …

CoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low
and middle-income countries including Brazil, where it was the mainstay of the first wave of …

Background We evaluated immunogenicity of SCB-2019, a subunit vaccine candidate
containing a pre-fusion trimeric form of the SARS-CoV-2 spike (S)-protein adjuvanted with …